Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Beyond buzzwords: Foxtrot Supply mounts protest of an increasingly online-only world
A large butcher block table stands between the owners of Foxtrot Supply Co. and its customers. But the found-object centerpiece of their Crossroads store is meant as a meeting place, not a barrier, said Ryan Hetu. “It’s alluring, inviting and kind of vulnerable,” the Foxtrot co-founder explained. Stitched into the high-traffic fabric of First Fridays…
Peek inside: Made in KC Marketplace offers a glimpse of its new Plaza store (Photos)
Amid the bustle of traffic and construction in one of Kansas City’s most dominant shopping destinations, the Made in KC Marketplace has quietly been taking shape on the Country Club Plaza. The retailer — which specializes in showcasing wares crafted by local makers — opened the doors of its new location with little fanfare this…
iWerx Gladstone to expand Northland coworking, incubator options in former racquetball club
Two years after launching its sprawling flagship site in North Kansas City, a premiere coworking community is expected to debut iWerx Gladstone in late fall. The two-story, 32,000-square-foot space — originally built as a racquetball club and renovated into a traditional office building in the mid 1980s — will be home to about 80 offices,…
STL exit: Welltodo founder credits firm’s acquisition to early support from KC startup community
With the final deal still in the works Friday, Chris Cardinal said the acquisition of St. Louis-based Welltodo by SensorRX wouldn’t have been possible without the pre-seed rallying of his fellow entrepreneurs in Kansas City. Though the company moved across the state in 2016 to be closer to the co-founder’s in-laws, Cardinal said, the foundation for…